Recent advances in acute promyelocytic leukaemia
- PMID: 28794865
- PMCID: PMC5538034
- DOI: 10.12688/f1000research.10736.1
Recent advances in acute promyelocytic leukaemia
Abstract
Acute promyelocytic leukaemia (APML) is a subtype of leukaemia arising from a distinct reciprocal translocation involving chromosomes 15 and 17, which results in the PML-RARA fusion gene. Over the past three decades, APML has been transformed from a highly fatal disease to a highly curable one. This drastic improvement is because of the introduction of a new treatment strategy with all-trans retinoic acid and, more recently, arsenic trioxide. The revolutionary treatment of APML has also paved the way for a new cancer treatment, which is genetically targeted therapy. In this review, we look into this amazing journey of transformation and provide recent advances in the management of APML.
Keywords: PML; RARA; leukemia.
Conflict of interest statement
Competing interests: The authors declare that they have no competing interests.No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.
Similar articles
-
Acute promyelocytic leukaemia (APML) with cryptic PML-RARA fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation.Br J Haematol. 2019 Jul;186(1):155-157. doi: 10.1111/bjh.15738. Epub 2018 Dec 26. Br J Haematol. 2019. PMID: 30585303 No abstract available.
-
How retinoic acid and arsenic transformed acute promyelocytic leukemia therapy.J Mol Endocrinol. 2022 Oct 11;69(4):T69-T83. doi: 10.1530/JME-22-0141. Print 2022 Nov 1. J Mol Endocrinol. 2022. PMID: 36112505 Review.
-
Acute promyelocytic leukaemia with a novel translocation t(16;17)(q12;p13): a case report.Malays J Pathol. 2016 Dec;38(3):311-313. Malays J Pathol. 2016. PMID: 28028302
-
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.Lancet Oncol. 2015 Oct;16(13):1295-305. doi: 10.1016/S1470-2045(15)00193-X. Epub 2015 Sep 14. Lancet Oncol. 2015. PMID: 26384238 Clinical Trial.
-
Pathogenesis, diagnosis and monitoring of residual disease in acute promyelocytic leukaemia.Acta Haematol. 2004;112(1-2):55-67. doi: 10.1159/000077560. Acta Haematol. 2004. PMID: 15179005 Review.
Cited by
-
The SUMO Pathway in Hematomalignancies and Their Response to Therapies.Int J Mol Sci. 2019 Aug 9;20(16):3895. doi: 10.3390/ijms20163895. Int J Mol Sci. 2019. PMID: 31405039 Free PMC article. Review.
-
Coagulation Abnormalities and Risk Assessment in Acute Promyelocytic Leukemia: An Experience From a Resource-Constraint Country.Cureus. 2022 Jun 17;14(6):e26026. doi: 10.7759/cureus.26026. eCollection 2022 Jun. Cureus. 2022. PMID: 35865439 Free PMC article.
-
Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management.PLoS One. 2022 Mar 21;17(3):e0264307. doi: 10.1371/journal.pone.0264307. eCollection 2022. PLoS One. 2022. PMID: 35312680 Free PMC article.
-
Overall survival of adult acute myeloid leukemia based on cytogenetic and molecular abnormalities during 5 years in a single center study.Saudi Med J. 2019 Nov;40(11):1171-1176. doi: 10.15537/smj.2019.11.24584. Saudi Med J. 2019. PMID: 31707416 Free PMC article.
-
Ubiquitin and SUMO conjugation as biomarkers of acute myeloid leukemias response to chemotherapies.Life Sci Alliance. 2020 Apr 17;3(6):e201900577. doi: 10.26508/lsa.201900577. Print 2020 Jun. Life Sci Alliance. 2020. PMID: 32303586 Free PMC article.
References
-
- Melnick A, Licht JD: Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 1999;93(10):3167–215. - PubMed
-
- Liu TX, Zhang JW, Tao J, et al. : Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood. 2000;96(4):1496–504. - PubMed
-
- Huang ME, Ye YC, Chen SR, et al. : Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72(2):567–72. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous